IART
Integra LifeSciences Holdings Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -7.7% ·
share flow -6.1% ·
net new positions -8.3%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | +6 | 47.61M | $854.64M | +10 | −4 |
| Q1 2026 | 80 | -2 | 47.10M | $443.79M | +5 | −7 |
| Q4 2025 | 82 | +1 | 50.51M | $627.34M | +2 | −1 |
| Q3 2025 | 15 | -2 | 31.34M | $449.05M | — | −2 |
| Q2 2025 | 14 | +1 | 26.22M | $321.73M | +1 | — |
| Q1 2025 | 10 | -2 | 8.70M | $191.38M | — | −2 |
| Q4 2024 | 12 | -1 | 8.85M | $200.63M | — | −1 |
| Q3 2024 | 12 | 0 | 6.56M | $119.23M | +1 | −1 |
| Q2 2024 | 12 | — | 9.27M | $269.75M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 2.85M | — | $64.70M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passive) | 2.85M | — | $64.70M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.51M | +13.8% | $56.84M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.51M | +13.8% | $56.84M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.51M | +13.8% | $56.84M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.51M | +13.8% | $56.84M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 1.58M | -13.6% | $35.77M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passive) | 1.58M | -13.6% | $35.77M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 733.55K | -28.3% | $16.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 733.55K | -28.3% | $16.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 501.40K | -25.3% | $11.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Norges Bank ✦ (passive) | 395.38K | +772.4% | $8.97M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 85.72K | +164.5% | $1.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 85.72K | +164.5% | $1.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 63.79K | -27.3% | $1.45M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 63.79K | -27.3% | $1.45M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 63.79K | -27.3% | $1.45M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 47.20K | -88.2% | $1.07M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 47.09K | +10.4% | $1.07M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Millennium Management ✦ | 21.95K | -88.6% | $497,758 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Arrowstreet Capital ✦ | 13.76K | +7.1% | $311,986 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Bridgewater Associates | $536,615 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 200 holders, 74.41M shares, $694.31M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.